Extracellular signal-regulated kinases associate with and phosphorylate DHPS to promote cell proliferation
Open Access
- 28 September 2020
- journal article
- research article
- Published by Springer Nature in Oncogenesis
- Vol. 9 (9), 1-11
- https://doi.org/10.1038/s41389-020-00271-1
Abstract
The ERK1/2 pathway is one of the most commonly dysregulated pathways in human cancers and controls many vital cellular processes. Although many ERK1/2 kinase substrates have been identified, the diversity of ERK1/2 mediated processes suggests the existence of additional targets. Here, we identified Deoxyhypusine synthase (DHPS), an essential hypusination enzyme regulating protein translation, as a major and direct-binding protein of ERK1/2. Further experiments showed that ERK1/2 phosphorylate DHPS at Ser-233 site. The Ser-233 phosphorylation of DHPS by ERK1/2 is important for its function in cell proliferation. Moreover, we found that higher DHPS expression correlated with poor prognosis in lung adenocarcinoma and increased resistance to inhibitors of the ERK1/2 pathway. In summary, our results suggest that ERK1/2-mediated DHPS phosphorylation is an important mechanism that underlies protein translation and that DHPS expression is a potent biomarker of response to therapies targeting ERK1/2-pathway.Keywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RP160667)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA193124, CA210929, CA216911, CA216437)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
This publication has 41 references indexed in Scilit:
- Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapyActa Pharmaceutica Sinica. B, 2018
- The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target (Review)International Journal of Molecular Medicine, 2017
- MEK1 and MEK2 inhibitors and cancer therapy: the long and winding roadNature Reviews Cancer, 2015
- Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein KinasesMicrobiology and Molecular Biology Reviews, 2011
- MAP kinase signalling pathways in cancerOncogene, 2007
- ERK implication in cell cycle regulationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl+ K562 leukemic cells by Gab2Blood, 2002
- Components of a New Human Protein Kinase Signal Transduction PathwayJournal of Biological Chemistry, 1995
- The ins and outs of Raf kinasesTrends in Biochemical Sciences, 1994
- ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGFCell, 1991